PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
07-Nov-2019 PredictImmune and the Crohn’s & Colitis Foundation announce start of jointly-sponsored study to validate PredictSURE IBD™, the first prognostic test for IBD, in the US market PredictImmune
07-Nov-2019 Hikma continues strong 2019 performance and reiterates full year guidance Hikma Pharmaceuticals PLC
07-Nov-2019 Immunomedics in software project with Ideagen to streamline document reviews of cancer treatment processes t reviews of cancer treatment processes Ideagen
07-Nov-2019 Making medicines of the future: Watson-Marlow Fluid Technology Group launches sterile ReNu SU Technology cartridge assemblies for the Quantum pump Watson-Marlow Fluid Technology Group
07-Nov-2019 TOT BIOPHARM (1875.HK) Proceeded with IPO raising over HK$500 million TOT BIOPHARM International Company Limited
07-Nov-2019 BerGenBio ASA: Invitation to Third Quarter 2019 Results Presentation and Webcast BerGenBio ASA
07-Nov-2019 Targovax ASA: Third Quarter 2019 Results Targovax
06-Nov-2019 Evofem Biosciences Reports Third Quarter 2019 Financial Results and Provides Corporate Update Evofem Biosciences, Inc.
06-Nov-2019 BioMarin to Highlight Innovative Development Pipeline at R&D Day on November 14th BioMarin Pharmaceutical Inc.
06-Nov-2019 Tocagen to Report Third Quarter 2019 Financial Results and Business Updates on Tuesday, November 12 Tocagen Inc.
06-Nov-2019 Natera Reports Third Quarter 2019 Financial Results Natera, Inc.
06-Nov-2019 Ardelyx Announces Presentation at Kidney Week 2019 Ardelyx
06-Nov-2019 Nektar Therapeutics Reports Financial Results for the Third Quarter of 2019 Nektar Therapeutics
06-Nov-2019 Ardelyx Reports Third Quarter 2019 Financial Results and Recent Highlights Ardelyx
06-Nov-2019 Sierra Oncology Announces Proposed Public Offering of Convertible Preferred Stock and Warrants Sierra Oncology
06-Nov-2019 Protagonist Therapeutics Announces First Patient Dosed in a Phase 2 Study of Oral IL-23 Receptor Antagonist PTG-200 (JNJ-67864238) in the Treatment of Crohn's Disease Protagonist Therapeutics, Inc.
06-Nov-2019 Statement from Center for Drug Evaluation and Research Director Janet Woodcock. M.D., on the agency's efforts to protect patients through postmarket drug safety surveillance practices U.S. Food and Drug Administration
06-Nov-2019 Ryvu Therapeutics Announces Presentations on CDK8 Inhibitor SEL120 at the 61st ASH Annual Meeting Ryvu Therapeutics S.A.
06-Nov-2019 Avantor® and NIBRT Collaborate to Advance Bioprocessing by Addressing Downstream Bottlenecks in Monoclonal Antibodies (mAbs) Production Avantor
06-Nov-2019 EACS 2019: ViiV Healthcare to present 17 abstracts from its portfolio addressing the diverse needs of people living with HIV ViiV Healthcare